|
Name |
4-Nonanone
|
Molecular Formula | C9H18O | |
IUPAC Name* |
nonan-4-one
|
|
SMILES |
CCCCCC(=O)CCC
|
|
InChI |
InChI=1S/C9H18O/c1-3-5-6-8-9(10)7-4-2/h3-8H2,1-2H3
|
|
InChIKey |
TYBCSQFBSWACAA-UHFFFAOYSA-N
|
|
Synonyms |
4-Nonanone; Nonan-4-one; 4485-09-0; Amyl Propyl Ketone; Propyl amyl ketone; Pentyl Propyl Ketone; Amylpropylketone; n-Pentyl n-propyl ketone; EINECS 224-770-4; SCHEMBL129432; DTXSID5063493; CHEBI:179604; ZINC2167283; LMFA12000148; MFCD00027286; AKOS009157392; DB-051253; CS-0362557; FT-0635322; N0427; D91706; A902353; Q31838919
|
|
CAS | 4485-09-0 | |
PubChem CID | 78236 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 142.24 | ALogp: | 2.8 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 10 | QED Weighted: | 0.516 |
Caco-2 Permeability: | -4.384 | MDCK Permeability: | 0.00001990 |
Pgp-inhibitor: | 0.422 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.912 |
30% Bioavailability (F30%): | 0.925 |
Blood-Brain-Barrier Penetration (BBB): | 0.998 | Plasma Protein Binding (PPB): | 76.42% |
Volume Distribution (VD): | 0.754 | Fu: | 23.50% |
CYP1A2-inhibitor: | 0.791 | CYP1A2-substrate: | 0.889 |
CYP2C19-inhibitor: | 0.227 | CYP2C19-substrate: | 0.605 |
CYP2C9-inhibitor: | 0.182 | CYP2C9-substrate: | 0.895 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.672 |
CYP3A4-inhibitor: | 0.028 | CYP3A4-substrate: | 0.135 |
Clearance (CL): | 8.505 | Half-life (T1/2): | 0.883 |
hERG Blockers: | 0.032 | Human Hepatotoxicity (H-HT): | 0.078 |
Drug-inuced Liver Injury (DILI): | 0.126 | AMES Toxicity: | 0.016 |
Rat Oral Acute Toxicity: | 0.067 | Maximum Recommended Daily Dose: | 0.024 |
Skin Sensitization: | 0.215 | Carcinogencity: | 0.046 |
Eye Corrosion: | 0.905 | Eye Irritation: | 0.98 |
Respiratory Toxicity: | 0.353 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001025 | 0.700 | D0AY9Q | 0.380 | ||||
ENC000232 | 0.548 | D0Y3KG | 0.325 | ||||
ENC000250 | 0.548 | D01QLH | 0.324 | ||||
ENC000254 | 0.545 | D0FD0H | 0.308 | ||||
ENC000454 | 0.543 | D03ZJE | 0.303 | ||||
ENC000487 | 0.537 | D0E4WR | 0.292 | ||||
ENC000245 | 0.500 | D09SRR | 0.275 | ||||
ENC000253 | 0.500 | D0UE9X | 0.273 | ||||
ENC000315 | 0.500 | D0XN8C | 0.265 | ||||
ENC000655 | 0.500 | D0H2YX | 0.264 |